P53 acetylation enhances Taxol-induced apoptosis in human cancer cells

Apoptosis

Volumn 18, Issue 1, 2013, Pages 110-120

  Kim, Jae Hyeong ^a,b   Yoon, Eun Kyung ^a,c   Chung, Hye Jin ^a   Park, Seong Yeol ^a   Hong, Kyeong Man ^a   Lee, Chang Hun ^a   Lee, Yeon Su ^a   Choi, Kyungho ^a,d   Yang, Young ^b   Kim, Kyungtae ^a   Kim, In Hoo ^a  

^a National Cancer Center   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Ewha Womans University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Acetylation; Apoptosis; HDAC inhibitor; p53; Sirt1; Taxol

Indexed keywords

MUTANT PROTEIN; PACLITAXEL; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SIRTUIN 1; SMALL INTERFERING RNA;

ACETYLATION; APOPTOSIS; ARTICLE; CANCER CELL; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; ENZYME INHIBITION; GENE DELETION; HUMAN; HUMAN CELL; NULL ALLELE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STABILITY; PUMA; UPREGULATION; WILD TYPE;

ACETYLATION; APOPTOSIS; CELL LINE, TUMOR; HISTONE DEACETYLASE INHIBITORS; HUMANS; PACLITAXEL; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872594782     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-012-0772-8     Document Type: Article

References (35)

1. Sackett DL, Fojo T (1999) Taxanes and other microtubule stabilizing agents. Cancer Chemother Biol Response Modif 18:59-80
2. 1 apoptosis. Apoptosis 2:463-470
3. Matson DR, Stukenberg PT (2011) Spindle poisons and cell fate: a tale of two pathways. Mol Interventions 11:141-150
4. Kops GJPL, Weaver BAA, Cleveland DW (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773-785
5. Sudo T, Nitta M, Saya H, Ueno NT (2004) Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res 64:2502-2508
6. Clarke PA, Allan LA (2010) Destruction's our delight: controlling apoptosis during mitotic arrest. Cell Cycle 9:4035-4036
7. Harley ME, Allan LA, Sanderson HS, Clarke PR (2010) Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. EMBO J 29:2407-2420
8. Wertz IE, Kusam S, Lam C et al (2011) Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 471:110-114
9. Blagosklonny MV, Fojo T (1999) Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 83:151-156
10. Wahl AF, Donaldson KL, Fairchild C et al (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2:72-79
11. Woods CM, Zhu J, McQueney PA, Bollag D, Lazarides E (1995) Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol Med 1:506-526
12. Lanni JS, Lowe SW, Licitra EJ, Liu JO, Jacks T (1997) p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 94:9679-9683
13. Delia D, Mizutani S, Lamorte G, Goi K, Iwata S, Pierotti MA (1996) p53 activity and chemotherapy. Nat Med 2:724-725
14. Giannakakou P, Nakano M, Nicolaou KC et al (2002) Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA 99:10855-10860
15. Kruse JP, Gu W (2009) Modes of p53 regulation. Cell 137:609-622
16. Ferreon JC, Lee CW, Arai M, Martinez-Yamout MA, Dyson HJ, Wright PE (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc Natl Acad Sci USA 106:6591-6596
17. Sykes SM, Stanek TJ, Frank A, Murphy ME, McMahon SB (2009) Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53. J Biol Chem 284:20197-20205
18. Yamaguchi H, Woods NT, Piluso LG et al (2009) p53 acetylation is crucial for its transcription-independent proapoptotic functions. J Biol Chem 284:11171-11183
19. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W (2008) Acetylation is indispensable for p53 activation. Cell 133:612-626
20. Stewart ZA, Tang LJ, Pietenpol JA (2001) Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner. Oncogene 20:113-124
21. Damia G, Filiberti L, Vikhanskaya F et al (2001) Cisplatinum and Taxol induce different patterns of p53 phosphorylation. Neoplasia 3:10-16
22. Ford J, Jiang M, Milner J (2005) Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival. Cancer Res 65:10457-10463
23. Bunz F, Dutriaux A, Lengauer C et al (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282:1497-1501
24. Vaziri H, Dessain SK, Ng Eaton E et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159
25. Ito A, Kawaguchi Y, Lai CH et al (2002) MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21:6236-6245
26. Liu T, Liu PY, Marshall GM (2009) The critical role of the class III histone deacetylase SIRT1 in cancer. Cancer Res 69:1702-1705
27. Saito A, Yamashita T, Mariko Y et al (1999) A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA 96:4592-4597
28. Beckers T, Burkhardt C, Wieland H et al (2007) Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer 121:1138-1148
29. Guntur VP, Waldrep JC, Guo JJ, Selting K, Dhand R (2010) Increasing p53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro. Anticancer Res 30:3557-3564
30. Shi X, Kachirskaia I, Yamaguchi H et al (2007) Modulation of p53 Function by SET8-Mediated Methylation at Lysine 382. Mol Cell 27:636-646
31. Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606
32. Lohrum MA, Woods DB, Ludwig RL, Balint E, Vousden KH (2001) C-terminal ubiquitination of p53 contributes to nuclear export. Mol Cell Biol 21:8521-8532
33. Loewer A, Batchelor E, Gaglia G, Lahav G (2010) Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell 142:89-100
34. Lassen U, Molife LR, Sorensen M et al (2010) A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours. Br J Cancer 103:12-17
35. Zuco V, De Cesare M, Cincinelli R et al (2011) Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo. PLoS ONE 6:e29085